SIRT2 and Cognitive impairment: Cerebrospinal fluid samples from patients with mild cognitive impairment caused by AD and a control group (i.e., patients with other neurological disorders) are analyzed using machine learning approaches, which identify SIRT2 with high differential performance and can be used as a novel biomarker of neuroinflammation in AD [21].